Sartorius completes acquisition of Novasep’s chromatography division

Sales revenue forecast for 2022 updated due to acquisition

08-Feb-2022 - Sartorius announced that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasepchromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission. The transaction had already been agreed upon at the beginning of 2021. The ...

Novasep invests EUR 30 million to build world's largest chromatography plant for the pharmaceutical industry

New plant on its Mourenx, France site to produce a large volume commercial API

15-Oct-2012 - Novasep announced an investment of EUR 30 million to build in Europe what will be the world's largest chromatography plant used for the production of a large volume commercial API (active pharmaceutical ingredient).The plant will be built on Novasep's existing Mourenx site in France and will be ...

Novasep and instrAction enter a worldwide strategic alliance for non-chiral chromatography

21-Jul-2010 - Novasep and instrAction announced that they have entered a strategic alliance. The alliance will offer customers in the life science industry a combination of instrAction’s proprietary API-selective stationary phases (Instruction® Receptor Phase) and Novasep purification capabilities and high ...

Novasep appoints two key executives

Stephen Stefano heads up Novasep North American business and Patrick Glaser leads Novasep Synthesis division

05-May-2010 - Novasep announced the appointments of two highly experienced managers in its drive to grow the group’s US presence and develop its Novasep Synthesis division. Stephen F. Stefano becomes President and CEO of Novasep North American business, and Patrick A. Glaser President and CEO of the Novasep ...

Novasep has Extended its Custom Chiral Separation Capabilities to Offer Optimized and Efficient Purification Solutions

Custom Chiral Separation Using Preparative Chromatography Eases and Speeds up Process Development; Rapidly and Efficiently Producing the Required Amount of Compounds for Early Development Phases While Being Cost Efficient at Industrial Scale

30-Sep-2008 - Novasep has recently added a state-of-the-art cGMP pilot scale continuous chromatography unit in its Chasse sur Rhône (France) facility. This ensures cost efficient separations of kilograms to tens of kilograms of pure enantiomer for clinical supplies. Novasep operates six FDA-inspected ...